$28.01−1.05 (−3.61%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Ionis Pharmaceuticals (IONS) Institutional Ownership
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
Sources Ownership filingsQuarter ended How we compute thisNot investment advice
5 figures withheld by our checks. Each blank figure names its reason.
13F fund flowQuarter ended Jun 30, 2026*. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 526 filers, Jun 30, 2026
# 13F FUNDS
526
13F VALUE
$14.8B
187.1M shares
Not reported in the company's filings for this period.
Insider trades · latest filings (Form 4)routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Hayden Michael R | director | Acquired · Open-market buy | 5,000 | $29.64 | ↗ |
| Oct 16, 2026 | Devers Shannon L. | EVP, Chief Human Resources Ofc | Disposed · Open-market sale | 1,357 | $43.54 | ↗ |
| Oct 16, 2026 | Swayze Eric | EVP Research | Disposed · Open-market sale | 53 | $43.54 | ↗ |
| Oct 15, 2026 | Devers Shannon L. | EVP, Chief Human Resources Ofc | Acquired · Option exercise | 2,820 | — | ↗ |
| Oct 15, 2026 | Devers Shannon L. | EVP, Chief Human Resources Ofc | Disposed · Option exercise | 2,820Restricted Stock Unit | — | ↗ |
| Oct 15, 2026 | Swayze Eric | EVP Research | Acquired · Option exercise | 125 | — | ↗ |
| Oct 15, 2026 | Swayze Eric | EVP Research | Disposed · Option exercise | 125Restricted Stock Unit | — | ↗ |
| Aug 31, 2026 | BENNETT C FRANK | EVP, Chief Scientific Officer | Acquired · Other | 110 | $51.31 | ↗ |
| Aug 31, 2026 | O'NEIL PATRICK R. | EVP CLO & General Counsel | Acquired · Other | 63 | $51.31 | ↗ |
| Aug 31, 2026 | Monia Brett P | Chief Executive Officer | Acquired · Other | 98 | $51.31 | ↗ |
| Aug 31, 2026 | Birchler Brian | EVP, Corp and Development Ops | Acquired · Other | 58 | $51.31 | ↗ |
| Jul 31, 2026 | Hayden Michael R | director | Acquired · Open-market buy | 5,000 | $51.60 | ↗ |
| Jul 30, 2026 | Hayden Michael R | director | Acquired · Open-market buy | 15,000 | $53.38 | ↗ |
| Jul 15, 2026 | Reikes Peter N | director | Acquired · Grant / award | 3,399Restricted Stock Unit | — | ↗ |
| Jul 15, 2026 | HANTSON LUDWIG | director | Acquired · Grant / award | 3,399Restricted Stock Unit | — | ↗ |
| Jul 15, 2026 | HERMAN JOAN E | director | Acquired · Option exercise | 5,220 | — | ↗ |
| Jul 15, 2026 | HERMAN JOAN E | director | Disposed · Option exercise | 5,220Restricted Stock Unit | — | ↗ |
| Jul 15, 2026 | BERTHELSEN SPENCER R | director | Acquired · Option exercise | 5,220 | — | ↗ |
| Jul 15, 2026 | BERTHELSEN SPENCER R | director | Disposed · Option exercise | 5,220Restricted Stock Unit | — | ↗ |
| Jul 7, 2026 | BENNETT C FRANK | EVP, Chief Scientific Officer | Disposed · Open-market sale | 5,536 | $83.58 | ↗ |
* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How many 13F filers hold Ionis Pharmaceuticals?
Ionis Pharmaceuticals was held by 526 13F filers as of Jun 30, 2026.
Not investment advice.

